IDiyas

For the Inventor, By the Inventor

Shiga, Japan

Hideyuki Takenaka

USPTO Granted Patents = 17

 

Average Co-Inventor Count = 4.5

ph-index = 9

Forward Citations = 285(Granted Patents)


Location History:

  • Koga, JP (1994 - 1995)
  • Shiga-ken, JP (1996)
  • Nabari, JP (1993 - 2001)
  • Osaka, JP (2002)
  • Koka-cho, JP (2007)
  • Shiga, JP (1993 - 2012)

Company Filing History:

goldMedal11 out of 1,001 
 
Shionogi Company Limited
 patents
silverMedal5 out of 25 
 
Shionogi Seiyaku Kabushiki Kaisha
 patents
bronzeMedal1 out of 1 
 
Shionogo & Co., Ltd
 patent

Years Active: 1993-2012

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents
1. 8115027 - NPY Y5 antagonist (2012-02-14),
2. 7265130 - NPY Y5 antagonist (2007-09-04),
3. 6800630 - Pyrimidine derivatives having antitumor effect (2004-10-05),
4. 6699891 - Npyy5 antagonists (2004-03-02),
5. 6420367 - Pyrimidine derivatives exhibiting antitumor activity (2002-07-16),
6. 6313150 - &agr;-substituted phenylacetic acid derivative, its production and agricultural fungicide containing it (2001-11-06),
7. 5948819 - .alpha.-substituted phenylacetic acid derivative, its production and (1999-09-07),
8. 5770614 - 2-(substituted phenyl)-2-alkoxyimino-N-alkylacetamide compounds and (1998-06-23),
9. 5548078 - Process for the preparation of alkoxyiminoacetamide derivatives and (1996-08-20),
10. 5414122 - Process for producing alpha-ketoamide derivative (1995-05-09),
11. 5401877 - Alkoxyiminoacetamide derivative (1995-03-28),
12. 5371223 - Alkoxyiminoacetamide derivatives and their use as fungicides (1994-12-06),
13. 5371222 - Alkoxyiminoacetamide derivatives and their use as fungicides (1994-12-06),
14. 5360810 - Phenylmethoxyimino compounds and agricultural fungicides containing them (1994-11-01),
15. 5258551 - Process for producing .alpha.-ketoamide derivative (1993-11-02),

Title: The Innovative Path of Hideyuki Takenaka

Introduction: Hideyuki Takenaka is a prominent inventor based in Shiga, Japan, known for his significant contributions to pharmaceutical innovations. With an impressive portfolio consisting of 17 patents, he has made notable strides in the field of drug development, particularly focusing on receptor antagonists.

Latest Patents: One of Hideyuki Takenaka's latest innovations is the NPY Y5 antagonist. This invention presents a pharmaceutical composition designed for use as an NPY Y5 receptor antagonist, featuring a compound defined by the formula (I). The molecular structure includes a component where R can be a lower alkyl, cycloalkyl, or similar structures, showcasing the innovative approach he employs in drug formulation.

Career Highlights: Throughout his career, Hideyuki has been associated with leading companies in the pharmaceutical sector, primarily Shionogi & Company Limited and Shionogi Seiyaku Kabushiki Kaisha. His work in these organizations has been pivotal in advancing drug discovery and therapeutic solutions, especially in the area of receptor-targeted medications.

Collaborations: In his journey, Hideyuki has collaborated with notable professionals such as Michio Masuko and Yoshio Hayase. These collaborations have led to fruitful innovations that enhance the effectiveness and safety of pharmaceutical treatments, underscoring the collaborative spirit prevalent in the field of scientific research.

Conclusion: Hideyuki Takenaka's contributions to the pharmaceutical industry exemplify the impact of innovative thinking in addressing complex medical challenges. His work not only reflects personal dedication but also the collaborative efforts that drive progress in the field. As he continues to develop new inventions, the scientific community eagerly anticipates further advancements from this influential inventor.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…